Wen-Fei Wei

1.3k total citations
17 papers, 706 citations indexed

About

Wen-Fei Wei is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Wen-Fei Wei has authored 17 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Wen-Fei Wei's work include Cancer Cells and Metastasis (5 papers), Extracellular vesicles in disease (3 papers) and Lymphatic System and Diseases (3 papers). Wen-Fei Wei is often cited by papers focused on Cancer Cells and Metastasis (5 papers), Extracellular vesicles in disease (3 papers) and Lymphatic System and Diseases (3 papers). Wen-Fei Wei collaborates with scholars based in China, United Kingdom and United States. Wen-Fei Wei's co-authors include Chenfei Zhou, Wei Wang, Luo-Jiao Liang, Sha Wu, Xiaojing Chen, Rui-Ming Yan, Xiang‐Guang Wu, Zi‐Ci Wang, Liangsheng Fan and Wei Wang and has published in prestigious journals such as Cell Death and Differentiation, Frontiers in Immunology and Molecular Therapy.

In The Last Decade

Wen-Fei Wei

16 papers receiving 704 citations

Peers

Wen-Fei Wei
Xiang‐Guang Wu China
Eslam A. Elghonaimy Egypt
Ji‐Shiang Hung Taiwan
Hua Linghu China
Antonio Agostini Norway
David Guerrero‐Setas Spain
Hsin‐Yi Lan Taiwan
Ge Lou China
Xiang‐Guang Wu China
Wen-Fei Wei
Citations per year, relative to Wen-Fei Wei Wen-Fei Wei (= 1×) peers Xiang‐Guang Wu

Countries citing papers authored by Wen-Fei Wei

Since Specialization
Citations

This map shows the geographic impact of Wen-Fei Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen-Fei Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen-Fei Wei more than expected).

Fields of papers citing papers by Wen-Fei Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen-Fei Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen-Fei Wei. The network helps show where Wen-Fei Wei may publish in the future.

Co-authorship network of co-authors of Wen-Fei Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Wen-Fei Wei. A scholar is included among the top collaborators of Wen-Fei Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen-Fei Wei. Wen-Fei Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chen, Peiyu, et al.. (2024). Tumor-to-stroma cd8+ t cells ratio combined with cancer-associated fibroblasts: an innovative approach to predicting lymph node metastases of cervical cancer. Journal of Cancer Research and Clinical Oncology. 150(2). 93–93. 3 indexed citations
2.
3.
Wei, Wen-Fei, Huiling Zhou, Peiyu Chen, et al.. (2023). Cancer-associated fibroblast-derived PAI-1 promotes lymphatic metastasis via the induction of EndoMT in lymphatic endothelial cells. Journal of Experimental & Clinical Cancer Research. 42(1). 160–160. 26 indexed citations
4.
Zhou, Chenfei, Wen-Fei Wei, Jing Ma, et al.. (2021). Cancer-secreted exosomal miR-1468-5p promotes tumor immune escape via the immunosuppressive reprogramming of lymphatic vessels. Molecular Therapy. 29(4). 1512–1528. 102 indexed citations
5.
Chen, Pei‐Yu, et al.. (2021). Cancer-Associated Fibroblast Heterogeneity: A Factor That Cannot Be Ignored in Immune Microenvironment Remodeling. Frontiers in Immunology. 12. 671595–671595. 49 indexed citations
6.
Chen, Xiaojing, Wen-Fei Wei, Zi‐Ci Wang, et al.. (2021). A novel lymphatic pattern promotes metastasis of cervical cancer in a hypoxic tumour-associated macrophage-dependent manner. Angiogenesis. 24(3). 549–565. 35 indexed citations
7.
Liang, Luo-Jiao, Yang Yang, Wen-Fei Wei, et al.. (2021). Tumor-secreted exosomal Wnt2B activates fibroblasts to promote cervical cancer progression. Oncogenesis. 10(3). 42 indexed citations
8.
Zhou, Chenfei, Yanmei Zhang, Rui-Ming Yan, et al.. (2020). Exosome-derived miR-142-5p remodels lymphatic vessels and induces IDO to promote immune privilege in the tumour microenvironment. Cell Death and Differentiation. 28(2). 715–729. 77 indexed citations
9.
Chen, Xiaojing, Zi‐Ci Wang, Wen-Fei Wei, et al.. (2019). Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment. Cell Death and Disease. 10(7). 508–508. 99 indexed citations
10.
Ma, Jing, Lan Yu, Fan Xu, et al.. (2019). Treatment and clinical outcomes of cervical cancer during pregnancy. Annals of Translational Medicine. 7(11). 241–241. 8 indexed citations
11.
Xu, Fan, Yanfang Li, Liangsheng Fan, et al.. (2018). Preoperative SCC-Ag and thrombocytosis as predictive markers for pelvic lymphatic metastasis of squamous cervical cancer in early FIGO stage. Journal of Cancer. 9(9). 1660–1666. 28 indexed citations
12.
Wei, Wen-Fei, Lingfei Han, Dan Liu, et al.. (2017). Orthotopic Xenograft Mouse Model of Cervical Cancer for Studying the Role of MicroRNA-21 in Promoting Lymph Node Metastasis. International Journal of Gynecological Cancer. 27(8). 1587–1595. 10 indexed citations
13.
Chen, Xiaojing, Lingfei Han, Xiang‐Guang Wu, et al.. (2017). Clinical Significance of CD163+ and CD68+ Tumor-associated Macrophages in High-risk HPV-related Cervical Cancer. Journal of Cancer. 8(18). 3868–3875. 78 indexed citations
14.
Han, Lingfei, Chenfei Zhou, Wen-Fei Wei, et al.. (2017). TGF‐β1‐induced CK17 enhances cancer stem cell‐like properties rather than EMT in promoting cervical cancer metastasis via the ERK1/2‐MZF1 signaling pathway. FEBS Journal. 284(18). 3000–3017. 47 indexed citations
15.
Wei, Wen-Fei, Lina He, Lin Lü, et al.. (2015). [Study of integrated state of HPV-16 infection in cervical cancer and precancerous tissues].. PubMed. 35(1). 47–50. 4 indexed citations
16.
Xie, Dacheng, Jiujie Cui, Tian Xia, et al.. (2015). Hippo transducer TAZ promotes epithelial mesenchymal transition and supports pancreatic cancer progression. Oncotarget. 6(34). 35949–35963. 54 indexed citations
17.
He, Lina, Wen-Fei Wei, Liang Li, et al.. (2014). The efficacy of neoadjuvant chemotherapy in different histological types of cervical cancer. Gynecologic Oncology. 134(2). 419–425. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiang‐Guang Wu Breakdown of academic impact, for papers by Eslam A. Elghonaimy Breakdown of academic impact, for papers by Ji‐Shiang Hung Breakdown of academic impact, for papers by Hua Linghu Breakdown of academic impact, for papers by Antonio Agostini Breakdown of academic impact, for papers by David Guerrero‐Setas Breakdown of academic impact, for papers by Hsin‐Yi Lan Breakdown of academic impact, for papers by Ge Lou
Rankless by CCL
2026